HealthSTATS International Ceased Operations in 2025
The shutdown ended support for the BPro blood pressure monitoring device and withdrew its global regulatory approvals.
Updated on Oct. 6, 2026 in Healthcare
Live Poll
Do you trust medical monitoring devices manufactured by smaller, specialized technology companies?
HealthSTATS International permanently wound down its business operations on December 31, 2025. This move ended all technical and commercial support for the firm’s BPro wrist-worn blood pressure device and resulted in the withdrawal of its regulatory approvals.
Why it matters
The company's dissolution effectively removes an established tonometry-based monitoring option from the medical device market. Providers and clinics previously utilizing the BPro hardware must now navigate a complete loss of support and the invalidation of the device's prior regulatory clearances.
The BPro device maintained a two-decade market presence before the company ceased all operations on December 31, 2025. The shutdown resulted in the immediate withdrawal of regulatory approvals previously held in Singapore, the United States, Europe, and Australia.
The players
HealthSTATS International
A Singapore-based medical technology company that specialized in cuff-calibrated, wrist-worn blood pressure monitoring hardware.
BPro
A tonometry-based medical device formerly approved for blood pressure monitoring in the United States, Europe, Australia, and Singapore.
The details
HealthSTATS International operated as a medical technology developer focusing on non-invasive monitoring. Its core BPro product utilized tonometry to estimate blood pressure, meeting technical validation criteria from both the European Society of Hypertension and ANSI/AAMI. With the company's closure, these units are no longer supported, rendering the devices non-compliant for clinical use where regulatory approval is a prerequisite for diagnostic equipment.
Timeline
December 31, 2025: HealthSTATS International officially ceased operations and terminated support for the BPro device.
Market Landscape
The BPro device previously served as an alternative to traditional cuff-based systems by meeting the ANSI/AAMI SP10:2002 validation criteria. The exit of HealthSTATS International marks the conclusion of a product line that had served the diagnostic market for two decades.
Operators currently utilizing BPro devices must seek alternative monitoring hardware immediately to ensure continued regulatory compliance. Financial and medical managers should verify that any replacement equipment carries current, valid regulatory approvals in their specific operating jurisdiction.
The takeaway
The dissolution of an established medical technology firm serves as a reminder to conduct periodic audits of all critical diagnostic infrastructure to ensure vendor longevity. Confirm the ongoing support status of any legacy equipment that relies on specific regulatory authorizations.
Further reading
For broader trends affecting clinical diagnostic equipment, visit the Healthcare section.
Source note: This article includes information reported by Nature.
Live Poll
Do you trust medical monitoring devices manufactured by smaller, specialized technology companies?
